{"id":47382,"date":"2022-08-17T14:02:32","date_gmt":"2022-08-17T12:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/"},"modified":"2022-08-17T14:02:32","modified_gmt":"2022-08-17T12:02:32","slug":"atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/","title":{"rendered":"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery"},"content":{"rendered":"<div>\n<p>\n<i>Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties<\/i>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/5\/atomwise-logo-for-white-800px.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg\"><\/a><\/p>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/AI?src=hash\" target=\"_blank\" rel=\"noopener\">#AI<\/a>&#8211;Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet<sup>\u00ae<\/sup> platform for computational discovery and research of up to five drug targets.\n<\/p>\n<p>\nThe Atomwise approach shifts the mode of drug discovery away from serendipitous discovery and toward search based on structure, making the drug discovery process more rational, effective, and efficient. The AtomNet platform incorporates deep learning for structure-based drug design, enabling the rapid, AI-powered search of Atomwise\u2019s proprietary library of more than 3 trillion synthesizable compounds.\n<\/p>\n<p>\n\u201cAt Sanofi, we are committed to bringing higher quality medicines to patients faster, empowered by our advanced AI drug discovery engine. We are excited to partner with Atomwise, given their leadership in the field of virtual screening and AI-based molecular design,\u201d said Frank Nestle, Global Head of Research and Chief Scientific Officer at Sanofi. \u201cTogether, we aim at making the drug discovery process more efficient and effective in particular when very limited information is available to support drug design.\u201d\n<\/p>\n<p>\nAs part of this agreement, Sanofi will pay Atomwise $20 million upfront to identify, synthesize, and advance lead compounds for up to five targets which will be exclusive to Sanofi. Subsequent payments pegged to key research, development, and sales milestones could total more than $1 billion. In addition, tiered royalties have been established for products developed through the collaboration.\n<\/p>\n<p>\n\u201cAt Atomwise, our mission is to use our unique technology to make better medicines, faster, by unlocking targets that have been inaccessible to traditional small molecule discovery approaches,\u201d said Abraham Heifets, co-founder and CEO of Atomwise. \u201cWe are pleased to enter into this collaboration with Sanofi, which serves as continued validation of the important role that AI-powered platforms will play in accelerating the discovery of new therapies for diseases and conditions that may have gone untreated due to challenging or uncharacterized drug targets.\u201d\n<\/p>\n<p>\nAbout Atomwise\n<\/p>\n<p>\nAtomwise is a technology-enabled pharmaceutical company leveraging the power of AI to revolutionize small molecule drug discovery. The Atomwise team invented the use of deep learning for structure-based drug design; this technology underpins Atomwise\u2019s best-in-class AI discovery engine, which is differentiated by its ability to find and optimize novel chemical matter. Atomwise has extensively validated its discovery engine, having demonstrated the ability to find compounds with therapeutic potential for biological targets in 90% of internal programs and more than 70% of the company\u2019s 270 academic collaborations, including across a wide variety of protein types and multiple \u201chard to drug\u201d targets. Atomwise is building a wholly-owned pipeline of small-molecule drug candidates, with three programs in lead-optimization and over 30 programs in discovery. The company has raised over $194 million from leading venture capital firms and collaborations to advance its mission to make better medicines, faster. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fatomwise.com%2F&amp;esheet=52816143&amp;newsitemid=20220817005089&amp;lan=en-US&amp;anchor=atomwise.com&amp;index=1&amp;md5=7543471f129e9f0edda7d4191577425c\" rel=\"nofollow noopener\" shape=\"rect\">atomwise.com<\/a> or follow <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FAtomwiseInc&amp;esheet=52816143&amp;newsitemid=20220817005089&amp;lan=en-US&amp;anchor=%40AtomwiseInc&amp;index=2&amp;md5=845c1fe1cddca426dda9cbc35cc24aed\" rel=\"nofollow noopener\" shape=\"rect\">@AtomwiseInc<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#x3a;&#x6d;&#101;&#x64;i&#97;&#x40;a&#116;&#x6f;&#109;&#x77;i&#115;&#x65;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;e&#x64;&#105;a&#x40;&#97;&#x74;&#111;m&#x77;&#105;&#x73;&#101;&#46;&#x63;&#111;&#x6d;<\/a><br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;i&#110;&#x76;e&#x73;&#x74;&#111;&#x72;s&#64;&#x61;t&#x6f;&#x6d;&#119;&#x69;s&#101;&#x2e;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;n&#x76;&#101;s&#x74;&#111;&#x72;&#x73;&#64;&#x61;&#116;o&#x6d;&#119;&#x69;&#115;e&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#AI&#8211;Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet\u00ae platform for &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47382","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#AI&#8211;Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet\u00ae platform for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-17T12:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery\",\"datePublished\":\"2022-08-17T12:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/\"},\"wordCount\":510,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005089\\\/en\\\/1546051\\\/21\\\/atomwise-logo-for-white-800px.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/\",\"name\":\"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005089\\\/en\\\/1546051\\\/21\\\/atomwise-logo-for-white-800px.jpg\",\"datePublished\":\"2022-08-17T12:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005089\\\/en\\\/1546051\\\/21\\\/atomwise-logo-for-white-800px.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005089\\\/en\\\/1546051\\\/21\\\/atomwise-logo-for-white-800px.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/","og_locale":"en_US","og_type":"article","og_title":"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery - Pharma Trend","og_description":"Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;#AI&#8211;Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet\u00ae platform for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-17T12:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery","datePublished":"2022-08-17T12:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/"},"wordCount":510,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/","url":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/","name":"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg","datePublished":"2022-08-17T12:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220817005089\/en\/1546051\/21\/atomwise-logo-for-white-800px.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/atomwise-signs-strategic-multi-target-research-collaboration-with-sanofi-for-ai-powered-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47382"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47382\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}